Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 31 August 2023 31 August 2024 31 August 2024 15107225 Mr Matthew James Murray iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15107225 2023-08-30 15107225 2024-08-31 15107225 2023-08-31 2024-08-31 15107225 frs-core:CurrentFinancialInstruments 2024-08-31 15107225 frs-bus:PrivateLimitedCompanyLtd 2023-08-31 2024-08-31 15107225 frs-bus:FilletedAccounts 2023-08-31 2024-08-31 15107225 frs-bus:Micro-entities 2023-08-31 2024-08-31 15107225 frs-bus:AuditExempt-NoAccountantsReport 2023-08-31 2024-08-31 15107225 frs-bus:Director1 2023-08-31 2024-08-31
Registered number: 15107225
RARETROVE LTD
Unaudited Financial Statements
For The Year Ended 31 August 2024
Osome Ltd
Balance Sheet
Registered number: 15107225
2024
£
Current assets 8,662
Prepayments and accrued income 50
Creditors: Amounts Falling Due Within One Year (25,281 )
NET CURRENT LIABILITIES (16,569 )
TOTAL ASSETS LESS CURRENT LIABILITIES (16,569 )
NET LIABILITIES (16,569 )
CAPITAL AND RESERVES (16,569 )

Notes

1. General Information
RARETROVE LTD is a private company, limited by shares, incorporated in England & Wales, registered number 15107225 . The registered office is 86-90 Paul Street, London, EC2A 4NE, EC2A 4NE.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr Matthew James Murray
Director
25/10/2024